Atomwise Opens Applications for Historic AI Drug Discovery Awards
Wednesday, April 19, 2017 - 09:32
in Mathematics & Economics
/PRNewswire/ -- Atomwise Inc. seeks proposals from innovative university scientists to receive 72 potential medicines, generated specifically for their research by artificial intelligence. The Artificial Intelligence Molecular Screen (AIMS) program is designed to dramatically accelerate the race towards life-saving drugs by analyzing millions of compounds for each disease. Contributing cutting-edge AI technology and delivering physical molecules to as many as 100 labs, the program is the first of its kind.
